Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
Authorized prescription drugs in Canada have an eight-digit Drug Identification Number (DIN)
The TRIUMPH-4 trial showed that retatrutide at 12mg reduced: Systolic blood pressure: 14.0 mmHg reduction Non-HDL cholesterol: clinically meaningful improvement High-sensitivity C-reactive protein: significant reduction (a marker of systemic inflammation) Triglycerides: substantial decrease Tirzepatide produces similar cardiovascular improvements, with well-documented reductions in blood pressure, triglycerides, and inflammatory markers across the SURMOUNT and SURPASS programs
GHK-Cu works through fibroblast collagen synthesis and broad gene-expression modulation
Intranasal DSIP administration accelerated motor function recovery in rats after focal stroke, suggesting neuroprotective effects that extend well beyond sleep regulation
US$ 28.33
US$ 26.55
US$ 28.92
US$ 29.34
US$ 29.68
US$ 20.91
